Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon giftcards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!
Archives: Agenda
Designed to deliver: Unlocking the value of bespoke outsourcing models
- Move from siloed to integrated with a collaborative framework and culture
- Build an agile operating model for immediate and long-term success
- Unlock the value of strategic FSP: key examples of success
Tempus Ecosystem combines for smarter insight to precision medicine oncology trials
- Utilize multi-omics data from next-generation sequencing to build a smarter, data-driven trial design.
- Accelerate patient matching and enrollment through our extensive clinical trial site network.
- Combine these capabilities in an integrated ecosystem to build a better, more efficient clinical trial.
Afternoon refreshments and networking
Strategies for success when every patient counts: enhancing retention and protocol compliance in ultra-rare and genetic disorders
- In rare populations, every patient carries significant weight, making retention more critical than in most other therapeutic areas.
- Because patient numbers are extremely limited, attrition cannot be absorbed—losing even a single participant can jeopardize the entire study.
- Rare disease trials often focus heavily on recruitment, but retention is equally essential and frequently overlooked.
- Collaboration with the Community is key
- Case studies
Chair’s closing remarks and end of conference
Leverage the power of AI to optimize study site and CRA performance
- Growing trial complexity increases site questions and strains CRA resources
- RASPberry AI™ provides instant, accurate access to study-specific information
- Rapid answers improve site performance and CRA productivity
- Sponsors gain actionable insights into trial execution
Afternoon refreshments and networking
PANEL DISCUSSION: Effective collaboration in the trial ecosystem: How should pharma work with patient organizations and what are the best ways to engage with them?
- Highlighting and overcoming the pitfalls of working with patient groups and how to facilitate the outreach to ensure everyone is onboard
- Tackling lack of patient awareness: Improved methods of connecting community-based researchers with those in academic centers conducting trials
- Elevating trial credibility by better working with networks globally to find patients and identify the best centers
- Why patient advocacy groups are becoming gatekeepers for connecting sponsors and vendors
- Making trials more patient-focused rather than disease focused
Driving AI transformation in clinical trial financial management
- Discover how agentic AI streamlines and automates clinical trial financial workflows
- Learn how team roles evolve—from doing to reviewing
- Explore the key benefits of AI-driven payment processes in clinical trials
- Understand how a platform approach unifies end-to-end financial management